Development and validation of a prediction model for unsuccessful treatment outcomes in patients with multi-drug resistance tuberculosis

被引:3
|
作者
Ma, J-B [1 ]
Zeng, L-C [2 ]
Ren, F. [1 ]
Dang, L-Y [1 ]
Luo, H. [1 ]
Wu, Y-Q [1 ]
Yang, X-J [1 ]
Li, R. [1 ]
Yang, H. [3 ]
Xu, Y. [1 ]
机构
[1] Xian Chest Hosp, Dept Drug Resistance TB, Xian, Shaanxi, Peoples R China
[2] Xian Ctr Dis Control & Prevent, Xian, Shaanxi, Peoples R China
[3] Xian Chest Hosp, Dept Clin Lab, Xian, Shaanxi, Peoples R China
关键词
Tuberculosis; Drug resistance; Treatment outcome; Nomogram; Prediction; DRUG-RESISTANCE; RISK-FACTORS; CHINA; FAILURE; TB;
D O I
10.1186/s12879-023-08193-0
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
BackgroundThe World Health Organization has reported that the treatment success rate of multi-drug resistance tuberculosis is approximately 57% globally. Although new drugs such as bedaquiline and linezolid is likely improve the treatment outcome, there are other factors associated with unsuccessful treatment outcome. The factors associated with unsuccessful treatment outcomes have been widely examined, but only a few studies have developed prediction models. We aimed to develop and validate a simple clinical prediction model for unsuccessful treatment outcomes in patients with multi-drug resistance pulmonary tuberculosis (MDR-PTB).MethodsThis retrospective cohort study was performed between January 2017 and December 2019 at a special hospital in Xi'an, China. A total of 446 patients with MDR-PTB were included. Least absolute shrinkage and selection operator (LASSO) regression and multivariate logistic regression were used to select prognostic factors for unsuccessful treatment outcomes. A nomogram was built based on four prognostic factors. Internal validation and leave-one-out cross-validation was used to assess the model.ResultsOf the 446 patients with MDR-PTB, 32.9% (147/446) cases had unsuccessful treatment outcomes, and 67.1% had successful outcomes. After LASSO regression and multivariate logistic analyses, no health education, advanced age, being male, and larger extent lung involvement were identified as prognostic factors. These four prognostic factors were used to build the prediction nomograms. The area under the curve of the model was 0.757 (95%CI 0.711 to 0.804), and the concordance index (C-index) was 0.75. For the bootstrap sampling validation, the corrected C-index was 0.747. In the leave-one-out cross-validation, the C-index was 0.765. The slope of the calibration curve was 0.968, which was approximately 1.0. This indicated that the model was accurate in predicting unsuccessful treatment outcomes.ConclusionsWe built a predictive model and established a nomogram for unsuccessful treatment outcomes of multi-drug resistance pulmonary tuberculosis based on baseline characteristics. This predictive model showed good performance and could be used as a tool by clinicians to predict who among their patients will have an unsuccessful treatment outcome.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Treatment outcome of multi-drug resistant tuberculosis in the Republic of Moldova
    Vilc, Valentina
    Bivol, Stela
    Soltan, Viorel
    Seicas, Rita
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [42] Effectiveness of partial lung resection at multi-drug resistance of tuberculosis mycobacteria
    Sabirov, Shavkat
    Kariev, Tulkun
    Irgashev, Akram
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [43] Survival analysis of time to cure on multi-drug resistance tuberculosis patients in Amhara region, Ethiopia
    Yigzaw Alemu Limenih
    Demeke Lakew Workie
    BMC Public Health, 19
  • [44] Survival analysis of time to cure on multi-drug resistance tuberculosis patients in Amhara region, Ethiopia
    Limenih, Yigzaw Alemu
    Workie, Demeke Lakew
    BMC PUBLIC HEALTH, 2019, 19 (1)
  • [45] The function of the thyroid gland in patients with multi-drug resistant tuberculosis
    S. L. Matveyeva
    O. S. Shevchenko
    O. O. Pogorelova
    Antimicrobial Resistance & Infection Control, 6
  • [46] The function of the thyroid gland in patients with multi-drug resistant tuberculosis
    Matveyeva, S. L.
    Shevchenko, O. S.
    Pogorelova, O. O.
    ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, 2017, 6
  • [47] Pharmacokinetics of ofloxacin in patients with multi-drug resistant tuberculosis.
    Chun, H
    Shon, J
    Yoon, Y
    Kim, K
    Park, S
    Shin, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (02) : P85 - P85
  • [48] Multi-label classification for multi-drug resistance prediction of Escherichia coli
    Ren, Yunxiao
    Chakraborty, Trinad
    Doijad, Swapnil
    Falgenhauer, Linda
    Falgenhauer, Jane
    Goesmann, Alexander
    Schwengers, Oliver
    Heider, Dominik
    COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2022, 20 : 1264 - 1270
  • [49] Treatment outcomes among patients with multi-drug resistant tuberculosis in Abbassia Chest Hospital from July 2006 to June 2010
    Elmahallawy, Ibrahim I.
    Bakr, Ramadan M.
    Mabrouk, Ali A.
    Omar, Rasha M.
    EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2012, 61 (04): : 337 - 342
  • [50] Ambulatory Multi-Drug Resistant Tuberculosis Treatment Outcomes in a Cohort of HIV-Infected Patients in a Slum Setting in Mumbai, India
    Isaakidis, Petros
    Cox, Helen S.
    Varghese, Bhanumati
    Montaldo, Chiara
    Da Silva, Esdras
    Mansoor, Homa
    Ladomirska, Joanna
    Sotgiu, Giovanni
    Migliori, Giovanni B.
    Pontali, Emanuele
    Saranchuk, Peter
    Rodrigues, Camilla
    Reid, Tony
    PLOS ONE, 2011, 6 (12):